← Every applicant
Hibrow Hlthcare FDA Approvals
6 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| RAMELTEONNew drugJun 4, 2026TABLET, ORAL |
| FLUDROCORTISONE ACETATENew drugFeb 10, 2026TABLET, ORAL |
| HYDROCORTISONENew drugNov 25, 2024TABLET, ORAL |
| NIACINNew drugAug 25, 2023TABLET, EXTENDED RELEASE, ORAL |
| QUINIDINE GLUCONATENew drugSep 17, 2021TABLET, EXTENDED RELEASE, ORAL |
| POTASSIUM CITRATENew drugFeb 19, 2021TABLET, EXTENDED RELEASE, ORAL |